Literature DB >> 15928078

Humanized mice develop coronavirus respiratory disease.

Ralph S Baric1, Amy C Sims.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928078      PMCID: PMC1149438          DOI: 10.1073/pnas.0503091102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  22 in total

1.  Episodic evolution mediates interspecies transfer of a murine coronavirus.

Authors:  R S Baric; B Yount; L Hensley; S A Peel; W Chen
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut.

Authors:  S Zhang; V R Racaniello
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.

Authors:  Scott A Jeffers; Sonia M Tusell; Laura Gillim-Ross; Erin M Hemmila; Jenna E Achenbach; Gregory J Babcock; William D Thomas; Larissa B Thackray; Mark D Young; Robert J Mason; Donna M Ambrosino; David E Wentworth; James C Demartini; Kathryn V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

4.  Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses.

Authors:  R Vlasak; W Luytjes; W Spaan; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 5.  Coronavirus genome structure and replication.

Authors:  D A Brian; R S Baric
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

Review 6.  Coronavirus reverse genetics and development of vectors for gene expression.

Authors:  L Enjuanes; I Sola; S Alonso; D Escors; S Zúñiga
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

7.  Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13).

Authors:  Leen Vijgen; Els Keyaerts; Kalina Zlateva; Marc Van Ranst
Journal:  Int J Infect Dis       Date:  2004-07       Impact factor: 3.623

8.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

9.  Identification of a new human coronavirus.

Authors:  Lia van der Hoek; Krzysztof Pyrc; Maarten F Jebbink; Wilma Vermeulen-Oost; Ron J M Berkhout; Katja C Wolthers; Pauline M E Wertheim-van Dillen; Jos Kaandorp; Joke Spaargaren; Ben Berkhout
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

10.  Human aminopeptidase N is a receptor for human coronavirus 229E.

Authors:  C L Yeager; R A Ashmun; R K Williams; C B Cardellichio; L H Shapiro; A T Look; K V Holmes
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962

View more
  4 in total

Review 1.  Humanized mouse models of epstein-barr virus infection and associated diseases.

Authors:  Shigeyoshi Fujiwara; Go Matsuda; Ken-Ichi Imadome
Journal:  Pathogens       Date:  2013-03-14

Review 2.  Studying human pathogens in animal models: fine tuning the humanized mouse.

Authors:  Caroline Lassnig; Andreas Kolb; Birgit Strobl; Luis Enjuanes; Mathias Müller
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 2.788

Review 3.  Update on SARS research and other possibly zoonotic coronaviruses.

Authors:  Larry J Anderson; Suxiang Tong
Journal:  Int J Antimicrob Agents       Date:  2010-08-30       Impact factor: 5.283

Review 4.  Prediction and prevention of the next pandemic zoonosis.

Authors:  Stephen S Morse; Jonna A K Mazet; Mark Woolhouse; Colin R Parrish; Dennis Carroll; William B Karesh; Carlos Zambrana-Torrelio; W Ian Lipkin; Peter Daszak
Journal:  Lancet       Date:  2012-12-01       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.